Staff of the US FDA often did not record background information as required when reviewing orphan designation requests, the Government Accountability Office found, which GAO suggested called into question the extent of the agency's evaluations.
The findings may not be too dire however, as HHS argued the background information GAO said was missing is actually rarely available when a sponsor requests an orphan
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?